Creatine transporter and mitochondrial creatine kinase protein content in myopathies

Muscle and Nerve

Volumn 24, Issue 5, 2001, Pages 682-688

  Tarnopolsky, M A ^a,b   Parshad, A ^a   Walzel, B ^a   Schlattner, U ^a   Wallimann, T ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b ETH ZURICH   (Switzerland)

Author keywords

Creatine monohydrate; Dystrophy; Inflammatory myopathy; Mitochondrial disease

Indexed keywords

CREATINE; CREATINE KINASE; CREATINE PHOSPHATE; MITOCHONDRIAL ENZYME;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN TISSUE; INFLAMMATION; MITOCHONDRIAL MYOPATHY; MUSCLE BIOPSY; MUSCULAR DYSTROPHY; MYOPATHY; PRIORITY JOURNAL; SARCOMERE; SKELETAL MUSCLE; WESTERN BLOTTING;

ADULT; CARRIER PROTEINS; CREATINE; CREATINE KINASE; FEMALE; HUMANS; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUSCULAR DISEASES; MYOFIBRILS; PHOSPHATES; TISSUE EMBEDDING;

EID: 0035031453     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.1055     Document Type: Article

References (40)

1. 31P magnetic resonance spectroscopy study
2. Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy
3. The origin of urinary creatinine in progressive muscular dystrophy
4. Reversible brain creatine deficiency in two sisters with normal blood creatine level
5. Variations of muscle mitochondrial creatine kinase activity in mitochondrial diseases
6. Preincubation with creatine enhances levels of creatine phosphate and prevents anoxic damage in rat hippocampal slices
7. Creatine ingestion favorably affects performance and muscle metabolism during maximal exercise in humans
8. Dietary creatine monohydrate supplementation increases satellite cell mitotic activity during compensatory hypertrophy
9. Creatine supplementation in health and disease. Effects of chronic creatine ingestion in vivo: Down-regulation of the expression of creatine transporter isoforms in skeletal muscle
10. A Na(+)-dependent creatine transporter in rabbit brain, muscle, heart, and kidney, cDNA cloning and functional expression
11. Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation
12. Coordinate induction of energy gene expression in tissues of mitochondrial disease patients
13. Muscle creatine loading in men
14. The creatine kinase system in normal and diseased human myocardium
15. Oral creatine supplementation and athletic performance: A critical review
16. Direct evidence for the control of mitochondrial respiration by mitochondrial creatine kinase in oxidative muscle cells in situ
17. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis
18. Free radical-induced inactivation of creatine kinase: Influence on the octameric and dimeric states of the mitochondrial enzyme (Mib-CK)
19. Progressive loss of mitochondrial creatine phosphokinase activity in muscular dystrophy
20. In vivo muscle magnetic resonance spectroscopy in the clinical investigation of mitochondrial disease
21. Creatine and cyclocreatine attenuate MPTP neurotoxicity
22. Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease
23. +-creatine cotransporter in failing human myocardium and in experimental heart failure
24. Mitochondrial intermembrane inclusion bodies: The common denominator between human mitochondrial myopathies and creatine depletion, due to impairment of cellular energetics
25. 2+ handling and survival in mdx skeletal muscle cells
26. 2+ handling and survival in mdx skeletal muscle cells
27. Octamers of mitochondrial creatine kinase isoenzymes differ in stability and membrane binding
28. Mitochondrial creatine kinase is a prime target of peroxynitrite-induced modification and inactivation
29. Mitochondrial creatine kinase: A major constituent of pathological inclusions seen in mitochondrial myopathies
30. 2+ responses in muscles with combined mitochondrial and cytosolic creatine kinase deficiencies
31. Effect of creatine loading on neuromuscular fatigue threshold
32. Creatine monohydrate increases strength in patients with neuromuscular disease
33. Clinical, physiological, and histological features in a kindred with the T3271C MELAS mutation
34. Direct measurement of high-energy phosphate compounds in patients with neuromuscular disease
35. A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies
36. Performance and muscle fiber adaptations to creatine supplementation and heavy resistance training
37. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: The "phosphocreatine circuit" for cellular energy homeostasis
38. Creatine monohydrate in muscular dystrophies: A double-blind, placebo-controlled clinical study
39. Insulin-like growth factor-I and high protein diet decrease calpain-mediated proteolysis in murine muscular dystrophy
40. The therapeutic potential of oral creatine supplementation in muscle disease